Raynaud's | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

100 results for “Raynaud's”

Trials

View all 88 →

Raynaud's Treatment Study (RTS)

First posted Oct 28, 1999

Open Label Treprostinil Raynaud's Study

30 participants · First posted Aug 8, 2025

Botulinum Toxin in Raynaud's Phenomenon

24 participants · First posted Nov 18, 2021

Drugs

Isoxsuprine

Conditions: Arteriosclerosis Obliterans, Buerger's Disease +3 more

C₁₈H₂₃NO₃

Raynaud syndrome(Tritech Bio)

News

View all 10 →

FDA Grants Fast Track Designation to Yutrepia for Raynaud's Phenomenon in Systemic Sclerosis

Liquidia's YUTREPIA Receives FDA Fast Track Designation for Systemic Sclerosis-Associated Raynaud's Phenomenon

Aisa Pharma's AISA-021 Shows Promise in Phase 2 Trial for Systemic Sclerosis-Associated Raynaud's Phenomenon

Page 1 of 10